2-Phenylbenzo[D]Oxazole

2-Phenylbenzo[D]Oxazole

SCHEMBL395084

[Ir].c1ccc(-c2nc3ccccc3o2)cc1.c1ccc(-c2nc3ccccc3o2)cc1

nearest known ligand 0.72

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.72
RAB9A P51151 7/20 0.72
MEN1 O00255 4/20 0.72
KMT2A Q03164 4/20 0.72
ATM Q13315 1/20 0.72
HSD17B10 Q99714 6/20 0.68
ALDH1A1 P00352 5/20 0.68
HPGD P15428 6/20 0.66
SMN1; SMN2 Q16637 5/20 0.66
KDM4E B2RXH2 4/20 0.66
TP53 P04637 3/20 0.66
CASP3 P42574 2/20 0.62
SENP7 Q9BQF6 2/20 0.62
SENP6 Q9GZR1 2/20 0.62
POLB P06746 1/20 0.62
SENP8 Q96LD8 1/20 0.62
MMP2 P08253 1/20 0.62
MMP9 P14780 1/20 0.62
MMP8 P22894 1/20 0.62
MMP13 P45452 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Phenylbenzo[D]Oxazole SCHEMBL29819732 1.00 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL27567766 1.00 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL31738605 1.00 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL2458370 1.00 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL127448 1.00 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL29767802 1.00 NPC1 (0.72) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL29083041 0.98 NPC1 (0.70) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL10670878 0.98 NPC1 (0.70) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL30022108 0.98 NPC1 (0.70) NPC1RAB9AMEN1KMT2AATM
2-Phenylbenzo[D]Oxazole SCHEMBL29986166 0.98 NPC1 (0.70) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2278637-B2 Complexes of form L2MX UNIV PRINCETON (US) 2021-06-09 EP disclosed
US-10629827-B2 Organometallic complexes as phosphorescent emitters in organic LEDs THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2020-04-21 US disclosed
EP-1933395-B2 Complexes of form L2IrX UNIV PRINCETON (US) 2019-08-07 EP disclosed
EP-2610887-B1 Organic light emitting devices for illumination UNIVERSAL DISPLAY CORP (US) 2019-04-17 EP disclosed
EP-3379591-A1 COMPLEXES OF FORM L2MX The Trustees of Princeton University (US) 2018-09-26 EP disclosed
EP-2911211-B1 COMPLEXES OF FORM L2MX UNIV PRINCETON (US) 2018-05-02 EP disclosed
US-20170301869-A9 ORGANOMETALLIC COMPLEXES AS PHOSPHORESCENT EMITTERS IN ORGANIC LEDS THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2017-10-19 US disclosed
EP-1252803-B2 COMPLEXES OF FORM L2MX AS PHOSPHORESCENT DOPANTS FOR ORGANIC LEDS UNIV PRINCETON (US) 2015-09-02 EP disclosed
EP-2911211-A1 COMPLEXES OF FORM L2MX The Trustees of Princeton University (US) 2015-08-26 EP disclosed
EP-2278637-B1 Complexes of form L2MX UNIV PRINCETON (US) 2015-02-25 EP disclosed
EP-1576854-A2 ORGANIC LIGHT EMITTING DEVICES FOR ILLUMINATION Universal Display Corporation (US) 2005-09-21 EP disclosed
US-6902830-B2 Organometallic complexes as phosphorescent emitters in organic LEDs THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2005-06-07 US disclosed
US-20040262576-A1 Organometallic complexes as phosphorescent emitters in organic LEDs THOMPSON MARK E (US) 2004-12-30 US disclosed
US-6830828-B2 Combining bridged dimer with a Bronsted acid to make an organometallic complex containing monoanionic, didentate ligands, with a metal which forms octahedral complexes THE TRUSTEES OF PRINCETON UNIVERSITY 2004-12-14 US disclosed
WO-2004017678-A2 ORGANIC LIGHT EMITTING DEVICES FOR ILLUMINATION UNIVERSAL DISPLAY CORPORATION (US) 2004-02-26 WO disclosed
EP-1252803-A4 COMPLEXES OF FORM L 2?MX AS PHOSPHORESCENT DOPANTS FOR ORGANIC LEDS UNIV PRINCETON (US) 2003-04-16 EP disclosed
US-20030017361-A1 Organometallic complexes as phosphorescent emitters in organic LEDs THOMPSON MARK E (US) 2003-01-23 US disclosed
EP-1252803-A1 COMPLEXES OF FORM L 2?MX AS PHOSPHORESCENT DOPANTS FOR ORGANIC LEDS THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2002-10-30 EP disclosed
US-20020034656-A1 Organometallic complexes as phosphorescent emitters in organic LEDs THE UNIVERSITY OF SOUTHERN CALIFORNIA 2002-03-21 US disclosed
WO-2001041512-A1 COMPLEXES OF FORM L2MX AS PHOSPHORESCENT DOPANTS FOR ORGANIC LEDS THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2001-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10629827-B2 Organometallic complexes as phosphorescent emitters in organic LEDs MLX, L1CAM, POU5F1 NPC1 4450/4885RAB9A 3330/4885MEN1 2227/4885
US-20170301869-A9 ORGANOMETALLIC COMPLEXES AS PHOSPHORESCENT EMITTERS IN ORGANIC LEDS MLX, L1CAM, POU5F1 NPC1 4450/4885RAB9A 3330/4885MEN1 2227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.